Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EMvision Medical DevicesASX:EMV -1.75%28 3-Year EPS without NRI Growth Rate is -12.40% as of Jun. 2026. GuruFocus rates ASX:EMV with a GF Score™ of 28/100. The stock has 3 warning signs investors should review. Among 662 Medical Devices & Instruments companies, EMvision Medical Devices ranks worse than 75.08% on this metric.
During the past 3 years, the average EPS without NRI Growth Rate was -12.40% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 1.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 9 years, the highest 3-Year average EPS without NRI Growth Rate of EMvision Medical Devices was 34.30% per year. The lowest was -12.40% per year. And the median was -2.50% per year.
EMvision Medical Devices (ASX:EMV) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
EMvision Medical Devices 3-Year EPS without NRI Growth Rate Related Terms
ASX:EMV vs ABT, SYK, MDT: 3-Year EPS without NRI Growth Rate Comparison
For the Medical Devices subindustry, EMvision Medical Devices's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EMvision Medical Devices 3-Year EPS without NRI Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, EMvision Medical Devices's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where EMvision Medical Devices's 3-Year EPS without NRI Growth Rate falls into.
EMvision Medical Devices 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of -12.40% mean?
EMvision Medical Devices (ASX:EMV) has a 3-Year EPS without NRI Growth Rate of -12.40% as of Jun. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for EMvision Medical Devices and its competitors. According to the industry distribution chart, EMvision Medical Devices ranks #497 out of 662 companies in the Medical Devices & Instruments industry, placing it in the top 75.1%.
Is EMvision Medical Devices' 3-Year EPS without NRI Growth Rate too high?
EMvision Medical Devices' current 3-Year EPS without NRI Growth Rate is -12.40%. Based on the distribution chart, EMvision Medical Devices ranks #497 out of 662 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, EMvision Medical Devices has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does EMvision Medical Devices' 3-Year EPS without NRI Growth Rate compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, EMvision Medical Devices ranks #497 out of 662 companies for 3-Year EPS without NRI Growth Rate. This places EMvision Medical Devices in the lower half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 8.05. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Medical Devices & Instruments company?
The median 3-Year EPS without NRI Growth Rate among Medical Devices & Instruments companies is 8.05, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for EMvision Medical Devices and its competitors. For the Medical Devices & Instruments industry, the median 3-Year EPS without NRI Growth Rate is 8.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EMvision Medical Devices's current 3-Year EPS without NRI Growth Rate is -12.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EMvision Medical Devices stock overvalued right now?
EMvision Medical Devices (ASX:EMV) has a current 3-Year EPS without NRI Growth Rate of -12.40%. The current 3-Year EPS without NRI Growth Rate is -12.40%. EMvision Medical Devices' overall GF Score™ is 28/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For EMvision Medical Devices (ASX:EMV), the current 3-Year EPS without NRI Growth Rate is -12.40% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
EMvision Medical Devices Ltd is an Australian medical device company. The company is focused on the research and development, and commercialisation of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. Its focus is portable, cost-effective, and non-invasive brain scanners, including a bedside device (emu) and an ultra-lightweight pre-hospital device (First Responder). Its first indication targets acute stroke care, with a second planned indication in traumatic brain injury.
28GF Score
Get the complete analysis for ASX:EMV
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:EMV has been successfully added to your 
